SEATTLE - For the first time ever, there's a cancer treatment vaccine on the market, and a Seattle company is behind it. The biotech company Dendreon got approval Thursday from the Food and Drug ...
New research in Seattle supports a surprising link between a common health supplement and a dramatically increased risk of prostate cancer. It’s omega-3 fatty acids, derived from fatty fish and fish ...
First comprehensive assessment of DNA errors that drive advanced prostate cancer SEATTLE - A team of researchers at Fred Hutchinson Cancer Research Center and the University of Washington has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback